Strategy to enhance diabetes management across Canada
October 18, 2015
"The objectives of the National Diabetes Strategy are aligned with AstraZeneca's commitment to improve the lives of Canadians," said Catriona McMahon, Vice President Medical Affairs, AstraZeneca Canada. "We are proud to support a project that directs resources to family doctors and healthcare providers who are burdened with mounting patient volumes and increasingly complex diabetes cases."
Diabetes and its complications can seriously impact quality of life and bring devastating consequences to patients, including kidney problems, nerve damage, heart disease and blindness. When managed effectively, however, patients with diabetes can minimize risks and lead healthy lives.
"Ensuring the success of a national strategy for diabetes requires the support and collaboration of many stakeholders - government, the pharmaceutical industry and the medical community," said Dr. Mitch Shulman, Vice President Medical Affairs, Bristol-Myers Squibb Canada. "We're pleased to be contributing to this important initiative that has the potential to make a tremendous difference for the millions of Canadians living with diabetes."
Dr. Stewart Harris is a Professor at Western's Schulich School of Medicine & Dentistry with appointments in Family Medicine, Endocrinology & Metabolism and Epidemiology & Biostatistics. Harris also hold the Ian McWhinney Chair in Family Medicine Studies and is a scientist at the Lawson Health Research Institute.
Source: CANADIAN DIABETES ASSOCIATION